Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Biotech/Pharma - Finance
Brandon Capital Partners Dedicates $200 Million to Seeking the Next Big Thing 4/20/2015 3:46:38 PM
Boston VC Firm Atlas Venture Set Sights on Biotech Startups With $280 Million Fund and New Home 4/17/2015 6:24:13 AM
Medican Enterprises Extends Closing On Two Phoenix Area Properties 4/17/2015 10:34:39 AM
Life Science Start-Ups Salivate, As NEA Announces Record-Setting $3.1B Funds 4/15/2015 6:48:00 AM
This San Francisco Startup Wants to be the Salesforce of Biotech 4/16/2015 6:10:51 AM
Ascenion GmbH's Portfolio Company OMEICOS Therapeutics Raises EUR 6.2 Million In Series A To Advance Lead Candidate In Atrial Fibrillation 4/15/2015 10:30:00 AM
Biologics, Inc. (NC) Secures Over $29 Million In Copay Assistance For Cancer Patients In 2014 4/15/2015 8:25:55 AM
Clyde Biosciences, A Leading Drug Toxicity Testing Company, Closes Series A Investment 4/14/2015 11:02:40 AM
Innocrin Pharmaceuticals Raises $28 Million in Series D Financing 4/14/2015 10:19:55 AM
Castle Biosciences Secures $6 Million Credit Facility From Silicon Valley Bank 4/14/2015 8:02:42 AM
StemBioSys Closes $8 Million Series A Financing 4/14/2015 8:01:33 AM
Fidelity CEO Uses Personal Fortune to Bet on Cancer Related IPOs Like Coherus, Adaptimmune and Blueprint Medicines 4/10/2015 6:06:18 AM
Voyager Therapeutics Snags $60 Million With "Crossover" Investors as Analysts Predict an IPO 4/13/2015 6:01:55 AM
Angionetics Initial Equity Funding To Advance As Independent Company To Develop And Commercialize Phase 3 Generx Gene Therapy Product Candidate 4/13/2015 7:36:23 AM
Embera NeuroTherapeutics, Inc. Secures A-2 Financing To Advance EMB-001 For Addictions Through Phase 1 Clinical Trial 4/10/2015 11:45:39 AM
1234567
//-->